Before the upcoming analytica in April 2012 the high-tech company posted the datasheet on www.cellasys.com to allow customers to use the BioChips independent of the proprietary IMOLA-IVD technology. Dr. Joachim Wiest, CEO of cellasys, states: „With opening the interface description we welcome new partners to integrate our BioChips into their own devices.“ Joint developments with a partner for live cell imaging are already ongoing.
cellasys is participating at analytica in hall B2 booth 307/412.